Evidence map›Paper›PMID 28388292›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.

Jolyn S Taylor, Suja S Rajan, Ning Zhang, Larissa A Meyer, Lois M Ramondetta, Diane C Bodurka, David R Lairson, Sharon H Giordano

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Hispanics and Hospice: A Systematic Literature Review.The American journal of hospice & palliative care · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Disparities in place of death for patients with primary brain tumors and brain metastases in the USA.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Racial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jolyn S TaylorJolyn S. Taylor, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Diane C. Bodurka, and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center; and Suja S. Rajan and David R. Lairson, The University of Texas School of Public Health, Houston, TX.
Suja S RajanJolyn S. Taylor, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Diane C. Bodurka, and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center; and Suja S. Rajan and David R. Lairson, The University of Texas School of Public Health, Houston, TX.
Ning ZhangJolyn S. Taylor, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Diane C. Bodurka, and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center; and Suja S. Rajan and David R. Lairson, The University of Texas School of Public Health, Houston, TX.
Larissa A MeyerJolyn S. Taylor, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Diane C. Bodurka, and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center; and Suja S. Rajan and David R. Lairson, The University of Texas School of Public Health, Houston, TX.
Lois M RamondettaJolyn S. Taylor, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Diane C. Bodurka, and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center; and Suja S. Rajan and David R. Lairson, The University of Texas School of Public Health, Houston, TX.
Diane C BodurkaJolyn S. Taylor, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Diane C. Bodurka, and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center; and Suja S. Rajan and David R. Lairson, The University of Texas School of Public Health, Houston, TX.
David R LairsonJolyn S. Taylor, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Diane C. Bodurka, and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center; and Suja S. Rajan and David R. Lairson, The University of Texas School of Public Health, Houston, TX.
Sharon H GiordanoJolyn S. Taylor, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Diane C. Bodurka, and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center; and Suja S. Rajan and David R. Lairson, The University of Texas School of Public Health, Houston, TX.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
TEXAS CANCER PREVENTION AND CONTROL FY12 APPLICATIONU58DP003902 · DP · TEXAS STATE DEPT OF HEALTH SERVICES · PI DELGADO, EVELYN · 2012 to 2014
$25.3M
Training of Academic Gynecologic OncologistsT32CA101642 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ANIL K SOOD, Kathleen Schmeler · 2005 to 2026
$9.2M
Health Services Career Development: Improving Medical Decisions in Ovarian CancerK07CA201013 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MEYER, LARISSA ALEJANDRA · 2016 to 2020
$853k
NCCDPHP CDC HHS U58 DP003902NCI NIH HHS K07 CA201013NCI NIH HHS P30 CA016672NCI NIH HHS T32 CA101642
6 · The paper itself

Abstract

Purpose To assess disparities in end-of-life care among patients with ovarian cancer. Patients and Methods Using Texas Cancer Registry-Medicare data, we assessed patients with ovarian cancer deceased in 2000 to 2012 with at least 13 months of continuous Medicare coverage before death. Descriptive statistics and multivariate logistic regressions were conducted to evaluate end-of-life care, including chemotherapy in the final 14 days of life, intensive care unit (ICU) admission in the final 30 days of life, more than one emergency room (ER) or hospital admission in the final 30 days of life, invasive or life-extending procedures in the final 30 days of life, enrollment in hospice, enrollment in hospice during the final 3 days of life, and enrollment in hospice while not hospitalized. Results A total of 3,666 patients were assessed: 2,819 (77%) were white, 553 (15%) Hispanic, 256 (7%) black, and 38 (1%) other. A total of 2,642 (72%) enrolled in hospice before death, but only 2,344 (64%) died while enrolled. The median hospice enrollment duration was 20 days. In the final 30 days of life, 381 (10%) had more than one ER visit, 505 (14%) more than one hospital admission, 593 (16%) ICU admission, 848 (23%) invasive care, and 418 (11%) life-extending care. In the final 14 days of life, 357 (10%) received chemotherapy. Several outcomes differed for minorities compared with white patients. Hispanic and black patients were less likely to enroll and die in hospice (black odds ratio [OR], 0.66; 95% CI, 0.50 to 0.88; P = .004; Hispanic OR, 0.76; 95% CI, 0.61 to 0.94; P = .01). Hispanic patients were more likely to be admitted to an ICU (OR, 1.37; 95% CI, 1.05 to 1.78; P = .02), and black patients were more likely to have more than one ER visit (OR, 2.20; 95% CI, 1.53 to 3.16; P < .001) and receive a life-extending procedure (OR, 2.13; 95% CI, 1.49 to 3.04; P < .001). Conclusion We found being a minority was associated with receiving intensive and invasive end-of-life care among patients with ovarian cancer.

Indexed as

AgedAged, 80 and overBlack or African AmericanBlack PeopleFemaleHispanic or LatinoHospicesHumansMedicareOvarian NeoplasmsRegistriesTerminal CareTexasUnited StatesWhite People

Identifiers

PMID28388292
PMCPMC5455594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.